CPAVENAT
LIVE

Serial Number

79424747

Owner

Ceapro Inc.

Attorney

Karl M. Zielaznicki, Esq.

Filing Date

Jan 22, 2025

Add to watchlist:

No watchlists yet
View on USPTO

CPAVENAT Trademark

Serial Number: 79424747 • Registration: 8258291

CPAVENAT is a trademark filed by Ceapro Inc. on January 22, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 30 (Staple Foods). The application is currently registered and active.

Owner Contact Info

Ceapro Inc.

7824 - 51 Avenue NW

Entity Type: 03

Trademark Details

Filing Date

January 22, 2025

Registration Date

May 19, 2026

Published for Opposition

March 31, 2026

Goods & Services

Bread; flour and preparations made from cereals, namely, cereal bars, cereal-based snacks, and breakfast cereals; oat based food products, namely, processed oat bran, oat flour, oat starch, and oat noodles

Dietary and nutritional supplements for improving nail strength, supporting healthy skin and maintaining shiny hair; dietary and nutritional supplements for general health and wellbeing; nutritional supplements, cosmeceuticals being supplements with cosmetic effects, nutraceuticals for use as dietary supplements, and pharmaceuticals, all containing avenanthramides for the treatment and prevention of inflammation, inflammatory bowel syndrome, joint inflammation, atherosclerosis, and cancer; nutritional supplements, cosmeceuticals being supplements with cosmetic effects, nutraceuticals for use as dietary supplements, and pharmaceuticals, all containing oat beta glucan for modulating glucose metabolism, for preventing and treating metabolic diseases and disorders, and for lowering cholesterol; veterinary medicine products, namely, natural, non-antibiotic, anti-microbial preparations for the treatment of mastitis in animals; natural saponin-based dietary supplement preparations and pharmaceuticals preparations, all acting on the immune systems of animals and humans to help fight infection and disease; pharmaceutical medicine products for human and animal use, namely pharmaceutical preparations in the area of immunology and bioengineering for the treatment of immune-based diseases and disorders of the immune system, and oat based preparations for use in the diagnosis and monitoring of diabetes, and pharmaceutical preparations in cream, lotion and liquid gel forms for the moisturizing treatment of lips and skin and the anti-bacterial treatment of cold sores, herpes sores, acne and skin diseases, and pharmaceutical anti-irritant and moisturizing cream, and pharmaceutical immune system stimulants; pharmaceutical preparations for skin care, namely medicated sunscreens, medicated skin creams, gels, balms and lotions, medicated shampoo, medicated lip balm; health care products, namely anti-irritant and moisturizing cream and shampoo; nutritional supplements for animal feed, and nutritional supplements, namely oat based supplements; additives to animal fodder in the nature of dietary supplements for medical purposes; pharmaceuticals preparation for immune system and inflammation based diseases; avenanthramides and oat beta glucan for use as ingredients in nutritional supplements, nutraceuticals, and pharmaceuticals; medicated skin care preparations, namely, creams, lotions and gels; medicated skin preparations, namely, creams, lotions and gels containing oat beta glucan; bandages for skin wounds; medicated bandages for dressings; bandages impregnated with oat beta glucan for medicinal purposes; medicinal oils other than essential oils

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 19, 2026 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 19, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 19, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 31, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 31, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 25, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 9, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 17, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 16, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 16, 2026 TROA
REFUSAL PROCESSED BY IB
Aug 30, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 14, 2025 RFCS
REFUSAL PROCESSED BY MPU
Aug 14, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 3, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jul 2, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 1, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
May 30, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 30, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 29, 2025 REPR